New drug developed to treat lung cancer particularly prevalent in Hong Kong – South China Morning Post

South China Morning Post
The Department of Health in Hong Kong approved the use of the new drug this month, but local doctors believe it will take years before it can become first-line treatment in public hospitals as it costs around HK$40,000 per month. “The new medicine has …

…read more

From:: Hong Kong News By Google News

About the Author

Zennie Abraham
Zennie Abraham | Zennie Abraham or "Zennie62" is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.

Be the first to comment on "New drug developed to treat lung cancer particularly prevalent in Hong Kong – South China Morning Post"

Leave a comment

Open

Maria Ayerdi Kaplan

Close